Infectious Disease DTC and OTC Diagnostics: Strategies and Trends, Forecasts by Application, Channel and Country with Market Analysis, Executive Guides, Customisation and Market Opportunity Analysis 2022 to 2026
Publication date: May 10, 2022
“The end of the pandemic opens up a new market for diagnostic technology….”
COVID-19 awakens the sleeping giant of at-home diagnostics. OTC and DTC diagnostics are set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-sampling technology key.
Exciting technical developments (especially in the seesaw between PCR and immunoassay) hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report breaks forecasts out to 2026 by the following:
- Syndrome; Respiratory, STD, UTI, HxV, Other
- Channel; OTC, DTC HSG
- Country; USA, Canada, Germany, France, UK, RoEUR, Japan, China, S. Korea, RoAP, Brazil, Mexico, RoLA, ME&A, Global
If a country forecast is not already listed, purchasers can request individual country market size information, or other customization without additional charge with the corporate license.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it.
All report data is available in Excel format on request with the corporate license.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School